Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas

被引:20
作者
Adamkov, Marian [2 ]
Halasova, Erika [3 ]
Rajcani, Julius [4 ]
Bencat, Marian [4 ]
Vybohova, Desanka [5 ]
Rybarova, Silvia [6 ]
Galbavy, Stefan [1 ,7 ]
机构
[1] St Elizabeth Univ Hlth & Social Sci, Inst Lab Med, Bratislava 81000, Slovakia
[2] Comenius Univ, Jessenius Fac Med Martin, Dept Histol & Embryol, Martin, Slovakia
[3] Comenius Univ, Jessenius Fac Med Martin, Dept Med Biol, Martin, Slovakia
[4] Alpha Med As, Anat Pathol Lab, Martin, Slovakia
[5] Comenius Univ, Jessenius Fac Med Martin, Dept Anat, Martin, Slovakia
[6] Safarik Univ, Fac Med, Dept Anat, Kosice, Slovakia
[7] Comenius Univ, Fac Med, Inst Forens Med, Bratislava, Slovakia
来源
MEDICAL SCIENCE MONITOR | 2011年 / 17卷 / 03期
关键词
p53; survivin; immunohistochemistry; basal cell carcinoma; WILD-TYPE P53; TUMOR-SUPPRESSOR PROTEIN; MALIGNANT-MELANOMA; NUCLEAR EXPRESSION; CASPASE ACTIVATION; APOPTOTIC PATHWAY; FAMILY PROTEINS; SPLICE VARIANTS; DNA DAMAGE; SKIN;
D O I
10.12659/MSM.881442
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The tumor suppressor gene p53 is a key regulator of cell division and/or apoptosis. Survivin is a multifunctional member of the inhibitor of apoptosis family. Survivin and p53 represent diametrically opposed signals that influence the apoptotic pathway. Material/Methods: To determine the role of p53 and survivin in basal cell carcinoma (BCC), we evaluated the expression pattern of both proteins with regard to the percentage of positively immunostained tumor cells, the intensity of staining, and subcellular localization among 31 subjects with BCC. Results: Overexpression of p53 protein was found in 28 of 31 cases (90.3%), whereas survivin accumulation was seen in 27 (87.1%). For p53, moderate and/or strong immunoreactivity was seen in 20 of 28 cases (71.4%), and 26 of 28 cases (92.9%) showed more than 25% reactive tumor cells. Nuclear p53 staining was detected in 23 of 28 cases (82.1%), whereas combined nuclear and cytoplasmic localization was found in only 5 of 28 cases (17.9%). Survivin revealed mild intensity of immunoreaction in 22 of 27 cases (71%), and 25 of 27 cases (92.6%) showed less than 25% labeled tumor cells. Combined nuclear and cytoplasmic survivin localization was present in 26 of 27 cases (96.3%). Statistically significant differences were detected in the assessed expression parameters between those proteins. Conclusions: Our results suggest that overexpression of wild type p53 protein may suppress the expression of survivin and its antiapoptotic activity in BCC cells.
引用
收藏
页码:BR74 / BR80
页数:7
相关论文
共 55 条
  • [1] Expression pattern of anti-apoptotic protein survivin in dysplastic nevi
    Adamkov, M.
    Lauko, L.
    Balentova, S.
    Pec, J.
    Pec, M.
    Rajcani, J.
    [J]. NEOPLASMA, 2009, 56 (02) : 130 - 135
  • [2] Validating survivin as a cancer therapeutic target
    Altieri, DC
    [J]. NATURE REVIEWS CANCER, 2003, 3 (01) : 46 - 54
  • [3] Role of nuclear factor-κB in melanoma
    Amiri, KI
    Richmond, A
    [J]. CANCER AND METASTASIS REVIEWS, 2005, 24 (02) : 301 - 313
  • [4] Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma
    Bäckvall, H
    Strömberg, S
    Gustafsson, A
    Asplund, A
    Sivertsson, Å
    Lundeberg, J
    Ponten, F
    [J]. EXPERIMENTAL DERMATOLOGY, 2004, 13 (10) : 643 - 650
  • [5] Survivin does not inhibit caspase-3 activity
    Banks, DP
    Plescia, J
    Altieri, DC
    Chen, J
    Rosenberg, SH
    Zhang, HC
    Ng, SC
    [J]. BLOOD, 2000, 96 (12) : 4002 - 4002
  • [6] Survivin 2α:: a novel survivin splice variant expressed in human malignancies
    Caldas, Hugo
    Honsey, Laura E.
    Altura, Rachel A.
    [J]. MOLECULAR CANCER, 2005, 4 (1)
  • [7] Expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin
    Chiodino, C
    Cesinaro, AM
    Ottani, D
    Fantini, F
    Giannetti, A
    Trentini, GP
    Pincelli, C
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) : 415 - 418
  • [8] Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
    Chipuk, JE
    Kuwana, T
    Bouchier-Hayes, L
    Droin, NM
    Newmeyer, D
    Schuler, M
    Green, DR
    [J]. SCIENCE, 2004, 303 (5660) : 1010 - 1014
  • [9] Basal cell carcinoma: biology, morphology and clinical implications
    Crowson, AN
    [J]. MODERN PATHOLOGY, 2006, 19 : S127 - S147
  • [10] Guardians of cell death:: the Bcl-2 family proteins
    Daniel, PT
    Schulze-Osthoff, K
    Belka, C
    Güner, D
    [J]. PROGRAMMED CELL DEATH, 2003, 39 : 73 - 88